# An Study to Evaluate Rosuvastatin in Children and Adolescents With Familial Hypercholesterolaemia

Study · id `cardio:ct-nct01078675` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01078675](<https://clinicaltrials.gov/study/NCT01078675>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01078675

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 315 participants.

## Technical summary

Registry record NCT01078675. Non-randomized; no masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2013-02 (actual). Results posted on 2015-02-02.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 315 participants (enrolled count; ClinicalTrials.gov record NCT01078675, source copy `cardio:ctgov-nct01078675-2015-04-07`, retrieved 2026-10-31)
- Start date: 2010-02 (registry gives no type) (ClinicalTrials.gov record NCT01078675, source copy `cardio:ctgov-nct01078675-2015-04-07`, retrieved 2026-10-31)
- Primary completion: 2013-02 (actual) (ClinicalTrials.gov record NCT01078675, source copy `cardio:ctgov-nct01078675-2015-04-07`, retrieved 2026-10-31)
- Completion: 2013-02 (actual) (ClinicalTrials.gov record NCT01078675, source copy `cardio:ctgov-nct01078675-2015-04-07`, retrieved 2026-10-31)
- Results first posted: 2015-02-02 (ClinicalTrials.gov record NCT01078675, source copy `cardio:ctgov-nct01078675-2015-04-07`, retrieved 2026-10-31)
- Countries: United States; Belgium; Canada; Netherlands; Norway (ClinicalTrials.gov record NCT01078675, source copy `cardio:ctgov-nct01078675-2015-04-07`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01078675-2015-04-07`, retrieved 2026-10-31)

## The registry's words

- Brief title: An Study to Evaluate Rosuvastatin in Children and Adolescents With Familial Hypercholesterolaemia
- Condition: Familial Hypercholesterolaemia
- Intervention (Drug): rosuvastatin calcium
- Intervention (Drug): rosuvastatin calcium
- Intervention (Drug): rosuvastatin calcium
- Lead sponsor: AstraZeneca
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: Familial hypercholesterolemia (`cardio:familial-hypercholesterolemia`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Rosuvastatin (`cardio:rosuvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)
- Registry lists this organization as the lead sponsor: AstraZeneca (`cardio:astrazeneca`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Hypercholesterolemia and reduced HDL-C promote hematopoietic stem cell proliferation and monocytosis: studies in mice and FH children (`cardio:pubmed-23684512`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c17955f7f3fb6cb3471fe5cda8d82611ba664649a681b8119b537394dda8ecfd
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
